A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01886820 |
|
Recruitment Status : Unknown
Verified July 2017 by Navidea Biopharmaceuticals.
Recruitment status was: Active, not recruiting
First Posted : June 26, 2013
Last Update Posted : July 26, 2017
|
Sponsor:
Navidea Biopharmaceuticals
Information provided by (Responsible Party):
Navidea Biopharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | June 2018 |
| Estimated Study Completion Date : | September 2018 |